Dr. Catherine Meyer smiling and looking at the camera

Catherine (Caffi) Meyer, PhD, DABR

Assistant Professor, Department of Molecular and Medical Pharmacology

Languages

English

Education

Fellowship

Diagnostic Imaging, Oregon Health & Science University, Portland, OR, 2024

Degrees

PhD, University of California, Los Angeles, CA, 2022
MS, University of California, Los Angeles, CA, 2019
BA, Carleton College, Northfield, MN, 2015

Contact Information

Scientific Interests

Dr. Meyer is a medical physicist specializing in nuclear medicine, quantitative imaging, and radiation dosimetry. Her research centers on image quantification, dosimetry calculations for nuclear medicine procedures, and the prediction and monitoring of responses to radiopharmaceutical therapies. Clinically, she is focused on integrating radiation dosimetry and other quantitative metrics to build towards more personalized treatments for patients.

Highlighted Publications

Stuparu A*, Meyer C*, Evans-Axelsson S, Lückerath K, Wei L, Kim W, Poddar S, Mona C, Dahlbom M, Girgis M, Radu CG, Czernin J, Slavik R. Targeted alpha therapy in a systemic mouse model of prostate cancer - a feasibility study. Theranostics. 2020; 10(6).

Meyer C, Dahlbom M, Lindner T, Vauclin S, Mona C, Slavik R, Czernin J, Haberkorn U, Calais J. Radiation dosimetry and biodistribution of 68Ga-FAPI-46 PET imaging in cancer patients. J Nucl Med. 2020; 61(8).

Urbán S, Meyer C, Dahlbom M, Farkas I, Sipka G, Besenyi Z, Czernin J, Calais J, Pávics L. Radiation dosimetry of 99mTc-PSMA-I&S: a single-center prospective study. J Nucl Med. 2021; 62(8).

Meyer C, Prasad V, Stuparu A, Kletting P, Glatting G, Miksch J, Solbach C, Lückerath K, Nyiranshitu L, Zhu S, Czernin J, Beer J, Slavik R, Calais J, Dahlbom M. Comparison of PSMATO- 1 and PSMA-617 labelled with 68Ga, 177Lu and 225Ac. EJNMMI Res. 2022; 12(1).

Meyer C, Stuparu A, Lückerath K, Calais J, Czernin J, Slavik R, Dahlbom M. Tandem isotope therapy with 225Ac- and 177Lu-PSMA-617 in a murine model of prostate cancer. J Nucl Med. 2023; 64(11).